StonvexLoading…
StonvexStonvexStonvexCore line items from GNTX's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2024 2024-09-30 | Annual 2024 2024-06-30 |
|---|---|---|---|---|
Revenue | $2.53B | $2.31B | $608.53M | $572.93M |
Operating Income | $473.94M | $459.73M | $125.73M | $114.88M |
Net Income | $384.84M | $404.49M | $122.55M | $86.04M |
EPS (Diluted) | $1.74 | $1.76 | $0.53 | $0.37 |
Total Assets | $2.93B | $2.76B | Not available | Not available |
Total Liabilities | $437.66M | $288.72M | Not available | Not available |
Cash & Equivalents | $145.65M | $233.32M | Not available | Not available |
Free Cash Flow OCF − CapEx | $458.04M | $353.54M | Not available | Not available |
Shares Outstanding | 215.45M | 227.21M | Not available | Not available |